DB

Dilip Bakhtawar Ranka

Active Director Whole-Time Director DIN 00337719
DIN 00337719 First appointment Jul 1989 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 4 active board seats
Past companies 2 historical roles
Total affiliations 6 Since Jul 1989
Shareholding value •••• Premium profile

About Dilip Bakhtawar Ranka

Data last updated:

Dilip Bakhtawar Ranka is a Whole-Time Director at Western Drugs Limited (since 2015), Additional Director at G.G.Valves Private Limited (since 2026) and Director at Ranka Organics Private Limited (since 2011), and holds 1 more current directorship. The companies operate in Healthcare, Machinery and Equipment and Chemicals and Materials. The 3 current companies with reported revenue have a combined latest revenue of ₹317 Cr; the largest is Western Drugs Limited at ₹236 Cr (FY 2025). Earlier, Dilip Bakhtawar Ranka was a Partner at Transmissions Limited Liability Partnership (from 2013) and Director at Transmissions Private Limited (from 1989).

DIN 00337719
Primary Designation Whole-Time Director
Industry Healthcare
First Appointment 01 Jul 1989
Oldest Company Age 69 yrs
Largest company Western Drugs Limited · ₹236 Cr (FY 2025)
Combined revenue ₹317 Cr across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Western Drugs Limited U24232RJ1989PLC004914
Whole-Time Director02 Mar 20151989₹236 Cr (FY 2025)Active
G.G.Valves Private Limited U17118RJ1984PTC003101
Additional Director20 Aug 20261984₹68.85 Cr (FY 2024)Active
Ranka Organics Private Limited U24232RJ1998PTC015016
Director27 Sep 20111998₹12.67 Cr (FY 2024)Active
Partner23 Aug 20162016Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Partner10 May 20132013Strike Off
Transmissions Private Limited U99999MH1957PTC010856
Director01 Jul 19891957Converted To Llp

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Transmissions Limited Liability Partnership
Global Translloy Metal Limited Liability Partnership
G.G.Valves Private Limited
Western Drugs Limited
Premium access

Shareholding and investment profile for Dilip Bakhtawar Ranka

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Dilip Bakhtawar Ranka

Dilip Bakhtawar Ranka currently holds 4 directorships: Western Drugs Limited (Whole-Time Director, since 02 Mar 2015, revenue ₹236 Cr (FY 2025)); G.G.Valves Private Limited (Additional Director, since 20 Aug 2026, revenue ₹68.85 Cr (FY 2024)); Ranka Organics Private Limited (Director, since 27 Sep 2011, revenue ₹12.67 Cr (FY 2024)); Global Translloy Metal Limited Liability Partnership (Partner, since 23 Aug 2016).

Dilip Bakhtawar Ranka was first appointed on 01 Jul 1989 as Director at Transmissions Private Limited. The most recent appointment on record is 20 Aug 2026 at G.G.Valves Private Limited.

The 3 current companies of Dilip Bakhtawar Ranka that report revenue have a combined latest revenue of ₹317 Cr: Western Drugs Limited ₹236 Cr (FY 2025); G.G.Valves Private Limited ₹68.85 Cr (FY 2024); Ranka Organics Private Limited ₹12.67 Cr (FY 2024).

Dilip Bakhtawar Ranka held 2 earlier board appointments: Transmissions Limited Liability Partnership (Partner, from 10 May 2013); Transmissions Private Limited (Director, from 01 Jul 1989).

The current boards of Dilip Bakhtawar Ranka's companies include Ankita Agrawal (Western Drugs Limited), Bhagwati Lal Dagliya (Western Drugs Limited), Jayantilal Ranka (Western Drugs Limited), Mahavir Ranka (Western Drugs Limited), Mishri Lal Lodha (Western Drugs Limited), Neha Bapna (Western Drugs Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available